don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Uromigos","authorlink":""},"src":"https:\/\/anchor.fm\/s\/13347ea8\/podcast\/play\/20839908\/https:\/\/d3ctxlq1ktw2nl.cloudfront.net\/staging\/2020-9-9\/51f99b2c-2bdd-407a-87c8-9135bbed6c10.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202106\/5a775e-0e9b-d998-92efa1_800.jpg"},"title":"Episode 63: The First Uromigos Debate: front line immune therapy vs maintenance avelumab in bladder cancer","link":"javascript:;","id":"item-691279"}]
